Morgan Awarded $1.2 Million in Federal Science, Tech Grants

(Photos Courtesy of Morgan State University)

Morgan State University Obtains $1.2 Million in Federal Science, Technology Grants

NSF and NIH Funding Boosts Morgan’s School of Computer, Mathematical and Natural Sciences

BALTIMORE — Morgan State University’s (MSU’s) School of Computer, Mathematical and Natural Sciences (SCMNS) has announced the receipt of four federal grants totaling more than $1.2 million, awarded in the spring and summer of 2020. The funds are supporting important research in science, technology, engineering and mathematics (STEM) fields ranging from pharmatechnology to advanced computing to meteorology to computer science instruction. Collectively, the grants indicate steady progress toward Morgan’s goal of attaining an R1 (“very high research”) designation from the Carnegie Classification of Institutions of Higher Education. MSU was elevated to an R2 (“high research”) Carnegie classification in December 2018.

“Receiving four grants by four different faculty members testifies to the quality of the faculty and their devotion to the

Read More

Morgan Stanley Analysts Reiterate $245 Price Target, See Promising Future in Microsoft’s Gaming Business

On Thursday, Morgan Stanley analysts reiterated their Overweight rating on Microsoft (MSFT) with a $245 price target. The analysts see great upside for Microsoft ahead of new Xbox console launches and following the $7.5B acquisition of game developer and publisher Bethesda Softworks.

The long-awaited release of the Xbox Series X/S console is approaching quickly. As expected, Microsoft should experience an uptick in hardware sales driven by the increase of “work/stay/play at home” activities from consumers. “The increase in gaming hardware revenue in FY21 vs.FY20 of $779 million in our model is already pressuring our existing FY21 gross margin estimates by ~35bps”, stated by Morgan Stanley analysts.

The analysts further noted: “Microsoft’s revenue base has grown meaningfully since (MSe $156 billion revenue in FY21 vs $110 billion in FY18), thus making the margin dilutive effect less meaningful now, in our view. Despite this modest gross margin headwind, we look for FY21

Read More

J.P. Morgan Analysts Reiterate Overweight Rating on Abbott Laboratories (ABT) and Raise Price Target Ahead of 3Q20 Earnings Release

On Friday, J.P. Morgan analysts reiterated their Overweight rating on Abbott Laboratories (ABT) while raising their price target from $110 to $125. The analysts give their insight on what they expect to see from 3Q20 results for Abbott Laboratories ahead of earnings season. They like MedTech and Diagnostic businesses combined with BinaxNow, Libre 3.0 and better Fx dynamics.

The analysts forecast 3Q20 revenue sales of $8.70B (+7.8% reported, +8.6%cc) and cash EPS of $0.92 (+9.4%). This is a bit higher than the Street forecast of $8.49B (+7.0%cc) and $0.90 EPS. Similar to the last quarter, better-than-expected COVID trends will work in Abbott’s favor. Medical Devices and Diagnostics is the main factor in representing most of upside given how consensus numbers haven’t moved for recent product announcements (i.e. Binax) and commentary.

J.P. Morgan analysts mentioned, “When combined with the tailwinds the company is seeing within diagnostics from its COVID-19 test approvals,

Read More

Apple’s ‘iPhone 12’ debut will be ‘most significant iPhone event in years,’ says Morgan Stanley

Ahead of Apple’s “iPhone 12” event on Oct. 13, Morgan Stanley is raising its iPhone estimates on new average selling price (ASP) analysis and iPhone build data.

In a research note to investors seen by AppleInsider, lead analyst Katy Huberty writes that the bank’s iPhone mix and pricing analysis indicates that Wall Street’s unit build and ASP estimates “remain too low” for 2021.

The upcoming “iPhone 12” and “iPhone 12 Pro” launch will be the “most significant iPhone event in years,” Huberty writes. She also points out that it comes at a key time for the company as device replacement cycles have lengthened to more than four years. Other factors could include increasing adoption of device trade-ins and gains in markets like Europe, the Middle East, and Asia.

Morgan Stanley’s Asia hardware technology team forecasts a total of 82 million iPhone builds in the December quarter, which suggests about

Read More

Morgan Stanley buying Boston-based Eaton Vance in deal valued at $7 billion

NEW YORK (AP) — Morgan Stanley is buying the investment management firm Eaton Vance in a deal valued at about $7 billion.

Eaton Vance, based in Boston, has over $500 billion in assets under management.

Morgan Stanley Chairman and CEO James P. Gorman said in a prepared statement Thursday that Eaton Vance will add more fee-based revenues to its investment banking and institutional securities franchise. The deal will give Morgan Stanley’s investment management arm approximately $1.2 trillion of assets under management and more than $5 billion of combined revenues.

Eaton Vance shareholders will receive $28.25 per share in cash and 0.5833 of Morgan Stanley common stock, or approximately $56.50 per share. Based on the $56.50 per share, the amount paid to Eaton Vance shareholders will consist of about 50 percent cash and 50 percent Morgan Stanley common stock.

Each Eaton Vance shareholder will have the option to choose all cash

Read More

Emails: Palantir blames Morgan Stanley for ‘blemished’ direct listing

  • In two emails sent internally this weekend, Palantir Technologies blamed Morgan Stanley for a “failure” that left some employee and alumni shareholders unable to sell their shares when the company made its public debut last Wednesday.
  • The problem stemmed from a glitch with Morgan Stanley’s trading platform Shareworks.
  • In an unsigned email sent late in the evening Sunday, Palantir said it had heard from Morgan Stanley that the bank was in a “war room” all weekend working to determine which shareholders were owed compensation. 
  • A spokesperson for Shareworks at Morgan Stanley said the issue was a “slowness” that “may have resulted in delayed logins into our system.”
  • Visit Business Insider’s homepage for more stories.

Palantir placed blame squarely on Morgan Stanley following a glitch in the bank’s trading software Shareworks on Wednesday, according two unsigned emails sent to “Palantirians” on Saturday and Sunday, which were obtained by Business Insider.

That

Read More

AppLovin hires Morgan Stanley to lead IPO

A man plays a game on a smartphone.

Brent Levin | Bloomberg | Getty Images

AppLovin, the U.S. mobile app and gaming company backed by private equity firm KKR, has hired Morgan Stanley to lead preparations for an initial public offering (IPO) which could come early in 2021, according to people familiar with the matter.

The company has flirted with the idea of an IPO for years, but had never taken a concrete preparatory step. It is the latest mobile gaming startup to eye a stock market listing, as demand for video games surges among consumers staying at home during the COVID-19 pandemic.

The sources requested anonymity because the IPO preparations are confidential and cautioned that the plans are subject to market conditions.

“Today gaming is a fractured, fragmented market. I think the market will consolidate, and I think AppLovin will be one of those consolidators,” Ted Oberwager, a managing

Read More

MORGAN STANLEY: Buy these 16 stocks to cheaply invest in next-generation technologies and reap the future profits they generate

  • Morgan Stanley says new technologies are feeding into a surge in productivity that will help the economy for years.
  • Strategist Adam Virgadamo says the pandemic will speed up that change, and investors don’t have to buy tech stocks to reap the rewards. 
  • He’s compiled a list of innovators that have been outperforming and look like they will continue to do based on their strategies and investments in their businesses.
  • Visit Business Insider’s homepage for more stories.

New technology has permeated so many industries and transformed business. But when investors want long-term growth, they’re mostly buying the same mega-cap tech stocks.

That’s stayed true even as some experts have warned about the sky-high prices of those same stocks, raising the spectre of the dot-com bubble 20 years ago and the dominance of a handful of giant stocks that hit record levels.

Whether there’s a bubble or not, Adam Virgadamo, a

Read More

European stock picks to buy, avoid in COVID recovery: Morgan Stanley

  • Morgan Stanley research teams, in a research note, outline the activity-based stocks that are still discounted for a post-COVID recovery across five different sectors.
  • Morgan Stanley recommends investors think about individual stocks instead of sectors.
  • “The bifurcation between winners and losers within sectors is arguably best exemplified within Retail – in aggregate, the sector has been a strong outperformer this year, but this largely reflects single-stock stories,” Morgan Stanley’s equity analyst, Jamie Rollo, said in a note.
  • Click here to sign up for our weekly newsletter Investing Insider.
  • Visit Business Insider’s homepage for more stories.

Morgan Stanley brought together five separate equity research teams to understand which European activity-based stocks damaged by the pandemic were still discounted for a post-COVID recovery, in a new research note released this week.

The investment bank is thinking ahead to recovery based on its biotech team expecting phase three vaccine results by November and

Read More